Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Publisher
Cancer Biology and Therapy(1)
Frontiers in Pharmacology(1)
World Journal of Surgical Oncology(1)
Origen
scopus(3)
Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: Report of a phase I trial
ArticleAbstract: 1E10 is an anti-idiotype murine monoclonal antibody (Ab2 MAb) specific to an Ab1 MAb which reacts wiPalabras claves:Anti-idiotype antibody, Cancer Vaccines, Clinical study, immunotherapyAutores:Alfonso A.M., Alonso D.F., Bárbara Wilkinson, Combet T., De La Torre A.V., Díaz A., Díaz R.M., Gabri M.R., Neninger Vinageras E., Pérez R., Rives R., Saurez G., Vázquez A.M.Fuentes:scopusEffect of blockade of the EGF system on wound healing in patients vaccinated with CIMAvax® EGF
ArticleAbstract: Background: The epidermal growth factor receptor (EGFR) signaling system is frequently unbalanced inPalabras claves:CIMAvax® EGF, EGF, eGFR, Wound healingAutores:Acosta Brooks S., Bárbara Wilkinson, Barroso Alvarez M.D.C., Carmen Elena Viada, Casacó Parada A.R., Crespo Diaz T., Fernández Lorente A., Martínez Pérez L.B., Neninger Vinageras E., Troche Concepción M.Fuentes:scopusSafety and immunogenicity of a human epidermal growth factor receptor 1 (HER1)-based vaccine in prostate castration-resistant carcinoma patients: A dose-escalation phase I study trial
ArticleAbstract: Metastatic castration-resistant prostate cancer (CRPC) remains incurable due to the lack of effectivPalabras claves:Human epidermal growth factor receptor, Immunogenicity, Prostate cancer, safety, Therapeutic vaccineAutores:Aira L.E., Bárbara Wilkinson, Caballero I., Casacó Parada A.R., Coba K., González J.G., González N., Lavastida A., Luaces P.L.o., Macías A.E., Mazorra Z., Mesa M., Popa X., Rivero J., Sanchez B., Santiesteban Y., Suárez E., Tania Crombet, Troche M.Fuentes:scopus